Nominating Committee

Keiko Ozato, Chair (2017-2019)
Sonja Marie Best (2018-2020)
Jean-Laurent Casanova (2018-2020)
Thomas Decker (2018-2020)
 Bryan Williams (2016-2018)

Awards Committee

Bryan Williams, Chair (2017-2019)
Kate Fitzgerald, Co-Chair (2017-2019)
Thomas B. Lavoie (2017 – 2019)
Nicola Ivan Lore (2015-2020)
Seth Masters (2015-2020)
Fabienne MacKay (2018-2020)
Masaaki Murakami (2018-2020)
Dane Parker (2015-2020)

Finance Committee

Cem GabayChair (2018-2020)
Katherine Fitzgerald (2018-202)
Nancy Reich (2016-2018)
John Schoggins (2018-2020)
Joan Oefner (Ex-Officio)

Meetings Committee

Brendan Jenkins, Chair (2017- 2019)

Chris Czarniecki (2014-2019)

Eleanor Fish (2017-2019)
Cem Gabay (2014-2019)
Curt Horvath (2014-2019)
Simon Jones (2017-2019Masato Kubo Ph.D. (2018 – 2020)

Development Committee

The purpose of the Development Committee is to facilitate interactions between the Society and Pharmaceutical and Biotechnology companies that are interested in cytokine & interferon research. The committee will work to provide guidance, suggestions, and history of interactions with industry to both the Society and to the Cytokine Conference Organizers, improving communication between the private sector and the Society.

David Artis  (2018-2020)
Eleanor Fish (2018-2020)
Richard Flavell (2018-2020)
Cem Gabay  (2018-2020)
Luke O’Neill (2018-2020)
Ad hoc:
Christopher Hunter (2018)
Kate Fitzgerald (2018)
Georg Schett (2018-2019)
Michael Gale (2018-2020)
Simon Jones (2018 – 2021)
Joan Oefner (ex-officio)

Membership & Communications Committee

Dusan Bogunovic, (Co-Chair 2017 – 2019)
Howard Young (Co-Chair 2018 – 2020)
Andrew Bowie (2014-2018)
Xuetao Cao (2014-2018)
Sarah Gaffen  (2016-2019)
Elizabeth Mann (2018 – 2020)
John Schoggins (2014-2020)
Di Yu (2018-2020)

Nomenclature Committee

Advise the international scientific community as to the appropriate classification of genes as interferon or interleukin genes. Evaluate the data in support or against such designations and they shall inform the major scientific journals if genes are to receive the interleukin or interferon designation.

Ludmila Prokunina-Olsson, Chair (2017-2019)
Rune Hartman (2017-2019)
Sergei Kotenko (2007-2019)
Erik Lundgren (2016 – 2019)
Juan Mendoza (2018 – 2020)

Publications Committee

Scott Durum, Chair (2017-2019)
Cristina Bergamaschi, Co-Chair (2017 – 2019)
Sandra Nicholson (2017-2019)
Kimberley Schluns (2017-2019)
Tomohiko Tamura (2017-2019)
Jennifer Towne (2017-2019)
Non-Voting Members:
Editors, Journal of Interferon & Cytokine Research, Michael Gale, Jr.
Editor, Cytokine Journal, Dhan Kalvakolanu

Standards Committee

Amanda Proudfoot, Biochemist, Chemokine biologist, Freelance Consultant, Rhone-Alpes, France, Chair, (2018 – 2020)
Joan Durbin, Rutgers New Jersey Medical School, Newark, USA, (2018 – 2020)
Georg Feger, Fresenius-Kabi SwissBioSim, Geneva, Switzerland, (2018-2020)
Eleanor Fish, University of Toronto, Toronto, Candada, (2018 – 2020)
Gareth Jones
, Cardiff University, Cardiff, Wales, UK, (2018 – 2020)
Meenu Wadhwa, Section Leader, Cytokines and Growth Factors, Division of Biotherapeutics, NIBSC, London, UK, (2013-2019)
Howard Young, Center for Cancer Research
National Cancer Institute
Frederick, USA (2018 – 2020)